31 October 2023 - From 1 November 2023, Australians with treatment resistant high frequency episodic migraine will have access to fremanezumab ...
27 October 2023 - Patients with terminal illnesses and painful chronic conditions have been offered hope thanks to a deal ...
30 October 2023 - The draft paper International Health Technology Market Approval, Funding and Assessment Pathways developed to support the ...
30 October 2023 - More Australians with chronic heart failure will have access to subsidised treatment under the PBS. ...
30 October 2023 - The agenda for this week's November 2023 meeting has been updated. ...
30 October 2023 - The Department of Health is seeking expressions of interest to fill three vacancies on the Pharmaceutical ...
28 October 2023 - Almost 100,000 patients are set to save hundreds of dollars per year as access to a ...
27 October 2023 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the July 2023 PBAC ...
23 October 2023 - Two more documents from the review are now available. ...
23 October 2023 - The Australian Government is giving more families access to life changing gene therapy for spinal muscular atrophy ...
23 October 2023 - On 1 November 2023, changes will be made to the authority requirements of the following biological ...
23 October 2023 - On 1 November 2023, changes will be made to the authority requirements of the PBS listing ...
16 October 2023 - From 1 October 2023, Australians with cervical cancer, urothelial cancer and spinal muscular atrophy will have access ...
13 October 2023 - The outcomes from the September 2023 PBAC intracycle meeting are now available. ...
11 October 2023 - The draft paper Horizon Scanning and Early Assessment developed to support the deliberations of the HTA ...